Ibhanti kunye neNdlela: Intsebenziswano, iHarmony kunye noWin-Win
iimveliso

Nutraceutical

  • I-Diosmin CAS: 520-27-4 uMboneleli woMvelisi

    I-Diosmin CAS: 520-27-4 uMboneleli woMvelisi

    I-Diosmin yi-disaccharide derivative equlathe i-diosmetin endaweni ye-6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety kwindawo yesi-7 ngoqhagamshelwano lwe-glycosidic.Inendima njenge-antioxidant kunye ne-anti-inflammatory agent.Yi-glycosyloxyflavone, i-rutinoside, i-disaccharide derivative, i-monomethoxyflavone kunye ne-dihydroxyflavanone.Ivela kwi-diosmetin.

  • ILiraglutide CAS: 204656-20-2 uMboneleli woMvelisi

    ILiraglutide CAS: 204656-20-2 uMboneleli woMvelisi

    I-Liraglutide, i-lipopeptide kunye ne-polypeptide, yi-analogue ye-GLP-1 yomntu apho intsalela ye-lysine kwindawo ye-27 itshintshwa yi-arginine kunye neqela le-hexadecanoyl elidityaniswe kwi-lysine eseleyo nge-spacer ye-glutamic acid.Isetyenziselwa kunye nokutya kunye nokuzivocavoca ukuphucula ulawulo lwe-glycemic kubantu abadala abane-type 2 yesifo sikashukela.I-Liraglutide isebenza njenge-glucagon-like peptide-1 receptor agonist kwaye isebenza njenge-neuroprotective agent.

  • I-TUDCA CAS: 14605-22-2 uMboneleli woMvelisi

    I-TUDCA CAS: 14605-22-2 uMboneleli woMvelisi

    I-Tauroursodeoxycholic acid (TUDCA) yi-hydrophilic bile acid eyenziwe kwi-hepatocytes ngokuhlanganiswa kwe-ursodeoxycholic acid (UDCA) kunye ne-amino acid taurine.I-UDCA, eyenziwe yintsholongwane yamathumbu, ivunyiwe yi-FDA e-United States kunyango lwezifo ezithile zesibindi se-cholestatic.Abantu benza i-TUDCA ukuya kuthi ga kwinqanaba elithile, kodwa ifumaneka kwiimali ezininzi kwi-bile yeebhere.I-TUDCA yi-classic inhibitor ye-endoplasmic reticulum (ER) yoxinzelelo.

  • I-Carnitine HCL CAS: 6645-46-1 uMboneleli woMvelisi

    I-Carnitine HCL CAS: 6645-46-1 uMboneleli woMvelisi

    I-Carnitine HCLyi-amino acid enendima eyidlalayo kwinkqubo yemetabolism yamafutha omzimba.I-L-Carnitine ihambisa i-fatty acids kwi-mitochondria, apho itshiswa khona njengamafutha.Le amino acid iyenzeka ngokwemvelo, nangona inokuthi ifakwe kwi-biosynthesized ukusuka kwezinye ezimbini.Ukongeza kokufunyanwa kuluhlu olubanzi lokutya, ikwafumaneka ngokuqhelekileyo njengesongezelelo sokutya.

  • I-Pioglitazone HCL CAS:112529-15-4 uMboneleli woMvelisi

    I-Pioglitazone HCL CAS:112529-15-4 uMboneleli woMvelisi

    I-Pioglitazone hydrochloride yi-agent yomlomo ye-antidiabetic esetyenziswa kunyango lwe-2 yesifo seswekile (ekwaziwa njenge-non-insulin-dependent diabetes mellitus (NIDDM) okanye isifo seswekile sabantu abadala. isehlo esisezantsi setyhefu ye-hepatic kunye namathuba aphantsi okudibana kweziyobisi.

  • I-Solifenacin Succinate CAS: 242478-38-2 uMboneleli woMvelisi

    I-Solifenacin Succinate CAS: 242478-38-2 uMboneleli woMvelisi

    I-Solifenacin succinate iyeza le-antimuscarinic elisetyenziselwa ukunyanga i-bladder esebenzayo ebangela iimpawu zokuphindaphinda, ukukhawuleza, okanye ukungazinzi.I-Solifenacin yi-M3 ye-muscarinic receptor antagonist eyaphuhliswa kwaye yaqaliswa ukunyangwa kwe-bladder esebenzayo (pollakiuria) eYurophu.Ii-receptors ze-M3 ziye zabandakanyeka kwi-neurally evoked smooth muscle contractions of the bladder, kunye ne-M2 receptors baye bakrokrelwa ukuba badlala indima ngenxa yokulawula kwabo kwi-detrusor muscle.

  • I-N-Acetyl-L-Alanine CAS:97-69-8 uMboneleli woMvelisi

    I-N-Acetyl-L-Alanine CAS:97-69-8 uMboneleli woMvelisi

    I-N-acetyl-L-amino acid eyi-L-alanine apho enye ye-hydrogens encanyathiselwe kwi-nitrogen ithathelwa indawo liqela le-acetyl.N-Acetyl-L-alanine/ 2-Acetylaminopropionic acid yikristale eqinileyo esetyenziswa kwi-acetyl group. I-immunodominant determinant ye-acidic surface antigen ukusuka kwinkcubeko yokuhluza yoxinzelelo lomntu lwe-Staph aureus.

  • I-Flutamide CAS: 13311-84-7 uMboneleli woMvelisi

    I-Flutamide CAS: 13311-84-7 uMboneleli woMvelisi

    I-Flutamide yi-monocarboxylic acid amide kunye nelungu le-(trifluoromethyl)benzenes.Inendima njenge-androgen antagonist kunye ne-antineoplastic agent.I-Flutamide luhlobo lwe-synthetic, i-non-steroidal antiandrogen esetyenziswa kakhulu kunyango lwe-prostate cancer.Luhlobo lwe-toluidine derivative kunye ne-nonsteroidal antiandrogen enesakhiwo esifanayo se-bicalutamide kunye ne-nilutamide.

  • I-Setmelanotide CAS:920014-72-8 uMboneleli woMvelisi

    I-Setmelanotide CAS:920014-72-8 uMboneleli woMvelisi

    I-Setmelanotide yi-agonist ye-melanocortin 4 receptor (MC4R), esebenza kumntu kunye ne-rat MC4R;Indlela yokusebenza kwe-MC4R nge-setmelanotide inokuhluka kwi-ligands yendalo kunye nesizukulwana sokuqala se-agonists zokwenziwa;Ukuseta i-melanotide kunokudlala indima ngokuchasa i-neurotransmitters ekhoyo ngokwemvelo kwaye inqanda ukusebenza kwe-MC4R;Kuye kwaqinisekiswa ukuba i-Setmelanotide inefuthe elihle kunyango lokukhuluphala kwaye ifikelele kwinqanaba lekliniki lesigaba sesi-3.

  • I-Arginine HCL CAS: 1119-34-2 uMboneleli woMvelisi

    I-Arginine HCL CAS: 1119-34-2 uMboneleli woMvelisi

    Arginine HCLluhlobo lwetyuwa lwe-L-Arginine, apho i-hydrochloric acid yongezwa ukuphucula uzinzo kunye nokunyibilika.IArginine hydrochloride yi-L-alpha-amino acid.I-amino acid ebalulekileyo esebenzayo ngokusebenza ngokomzimba kwi-L-form.I-L-Arginine inokusebenza ekwehliseni uxinzelelo lwegazi, ukunciphisa iimpawu ze-angina kunye ne-PAD, kunye nokunyanga ukungasebenzi kakuhle kwe-erectile ngenxa yesizathu somzimba.

  • I-L-Carnitine Fumarate CAS: 90471-79-7 uMboneleli woMvelisi

    I-L-Carnitine Fumarate CAS: 90471-79-7 uMboneleli woMvelisi

    I-L-Carnitine fumarate yindlela ezinzileyo ye-L-carnitine, kulula ukufunxa ukufuma njengomgubo omhlophe okanye i-crystalline powder, enyibilikayo emanzini.I-Fumarate yityuwa kunye ne-fumaric acid esters, isemzimbeni kunye neentlobo ezithile zendalo ezenzeka ngaphakathi kwe-moss. kunye namakhowa.Isetyenziswa ngokubanzi njengesongezo sokutya.

  • I-Linagliptin CAS: 668270-12-0 uMboneleli woMvelisi

    I-Linagliptin CAS: 668270-12-0 uMboneleli woMvelisi

    I-Linagliptin (amagama orhwebo i-Tradjenta kunye ne-Trajetna) sisithinteli se-dipeptidyl peptidase-4 (DPP-4) eyavunywa yi-US FDA ngoMeyi ka-2011 kunyango lwe-Type 2 yeswekile kunye nokutya kunye nokuzilolonga.I-Linagliptin (BI-1356) ichazwe njengeyona nto inamandla yokukhetha, isantya esicothayo kunye ne-inhibitor esebenza ixesha elide ye-DPP-4.I-Linagliptin ivele kwimizamo yokuphucula i-xanthine-based DPP-4 inhibitors kunye nesikhokelo sokuqala esichongiweyo kwiphulo le-HTS.